Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timm Weber

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancers|September 9, 2022
Concomitant Cytotoxic Effector Differentiation of CD4<sup>+</sup> and CD8<sup>+</sup> T Cells in Response to EBV-Infected B CellsYumi Tamura, Keita Yamane, Yohei Kawano, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2016
Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse lineVan Trung Chu, Robin Graf, Tristan Wirtz, et al.
Immunity|November 30, 2023
Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variantsMichael Korenkov, Matthias Zehner, Hadas Cohen-Dvashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2020
Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesisThomas Sommermann, Tomoharu Yasuda, Jonathan Ronen, et al.
Science Immunology|November 17, 2023
Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell poolTimm Weber, Sabrina Dähling, Svea Rose, et al.
Science Immunology|February 2, 2024
Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosisXun Li, Tristan Wirtz, Timm Weber, et al.
Immunity|January 6, 2022
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralizationTimm Weber, Julian Potthoff, Sven Bizu, et al.
Journal of Virology|September 23, 2025
Prediction of COVID-19 disease progression by multiparametric analysis of circulating extracellular vesicles with flow cytometryEvelyn Hammer, Charlotte Flynn, Johannes Rößler, et al.
Cell|July 17, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 PatientsChristoph Kreer, Matthias Zehner, Timm Weber, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancers|September 9, 2022
Concomitant Cytotoxic Effector Differentiation of CD4<sup>+</sup> and CD8<sup>+</sup> T Cells in Response to EBV-Infected B CellsYumi Tamura, Keita Yamane, Yohei Kawano, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2016
Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse lineVan Trung Chu, Robin Graf, Tristan Wirtz, et al.
Immunity|November 30, 2023
Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variantsMichael Korenkov, Matthias Zehner, Hadas Cohen-Dvashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2020
Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesisThomas Sommermann, Tomoharu Yasuda, Jonathan Ronen, et al.
Science Immunology|November 17, 2023
Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell poolTimm Weber, Sabrina Dähling, Svea Rose, et al.
Science Immunology|February 2, 2024
Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosisXun Li, Tristan Wirtz, Timm Weber, et al.
Immunity|January 6, 2022
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralizationTimm Weber, Julian Potthoff, Sven Bizu, et al.
Journal of Virology|September 23, 2025
Prediction of COVID-19 disease progression by multiparametric analysis of circulating extracellular vesicles with flow cytometryEvelyn Hammer, Charlotte Flynn, Johannes Rößler, et al.
Cell|July 17, 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 PatientsChristoph Kreer, Matthias Zehner, Timm Weber, et al.
Pageof 2